Skip to main content
Top
Published in: Current Treatment Options in Neurology 6/2013

01-12-2013 | SLEEP DISORDERS (S CHOKROVERTY, SECTION EDITOR)

Sleep-Related Headache and its Management

Published in: Current Treatment Options in Neurology | Issue 6/2013

Login to get access

Opinion statement

Sleep and headache have both generated curiosity within the human mind for centuries. The relationship between headache and sleep disorders is very complex. While Lieving in 1873 first observed that headaches were linked to sleep, Dexter and Weitzman in 1970 described the relationship between headache and sleep stages. Though our understanding of sleep and headache relationship has improved over the years with expanding knowledge in both fields and assessment tools such as polysomnography, it is still poorly understood. Headache and sleep have an interdependent relationship. Headache may be intrinsically related to sleep (migraine with and without aura, cluster headache, hypnic headache, and paroxysmal hemicrania), may cause sleep disturbance (chronic migraine, chronic tension-type headache, and medication overuse headache) or a manifestation of a sleep disorder like obstructive sleep apnea. Headache and sleep disorder may be a common manifestation of systemic dysfunction-like anemia and hypoxemia. Headaches may occur during sleep, after sleep, and in relation to different sleep stages. Lack of sleep and excessive sleep are both considered triggers for migraine. Insomnia is more common among chronic headache patients. Experimental data suggest that there is a common anatomic and physiologic substrate. There is overwhelming evidence that cluster headache and hypnic headaches are chronobiological disorders with strong association with sleep and involvement of hypothalamus. Cluster headache shows a circadian and circannual rhythmicity while hypnic headache shows an alarm clock pattern. There is also a preferential occurrence of cluster headache, hypnic headache, and paroxysmal hemicrania during REM sleep. Silencing of anti-nociceptive network of periaqueductal grey (PAG), locus ceruleus and dorsal raphe nucleus doing REM sleep may explain the preferential pattern. Sleep related headaches can be classified into (1) headaches with high association with obstructive sleep apnea, which includes cluster headache, hypnic headache, and headache related to obstructive sleep apnea; and (2) headaches with high prevalence of insomnia, medication overuse, and psychiatric comorbidity including chronic migraine and chronic tension-type headache. The initial step in the management of sleep related headache is proper diagnosis with exclusion of secondary headaches. Screening for sleep disorders with the use of proper tests including polysomnography and referral to sleep clinic, when appropriate is very helpful. Control of individual episode in less than 2 hours should be the initial goal using measures to abort and prevent a relapse. Cluster headache responds very well to injectable Imitrex and oxygen. Verapamil, steroids and lithium are used for preventive treatment of cluster headache. Intractable cluster headache patients have responded to hypothalamic deep brain stimulation. Hypnic headache patients respond to nightly caffeine, indomethacin, and lithium. Paroxysmal hemicrania responds very well to indomethacin. Early morning headaches associated with obstructive sleep apnea respond to CPAP or BiPAP with complete resolution of headache within a month. Patient education and lifestyle modification play a significant role in overall success of the treatment. Chronic tension-type headache and chronic migraine have high prevalence of insomnia and comorbid psychiatric disorders, which require behavioral insomnia treatment and medication if needed along with psychiatric evaluation. Apart from the abortive treatment tailored to the headache types, - such as triptans and DHE 45 for migraine and nonsteroidal anti-inflammatory medication for chronic tension-type headache, preventive treatment with different class of medications including antiepileptics (Topamax and Depakote), calcium channel blockers (verapamil), beta blockers (propranolol), antidepressants (amitriptyline), and Botox may be used depending upon the comorbid conditions.
Literature
1.
go back to reference Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.PubMedCrossRef Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.PubMedCrossRef
2.
go back to reference Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia. 2003;23(7):528–33.PubMedCrossRef Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia. 2003;23(7):528–33.PubMedCrossRef
3.
go back to reference Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache. 1995;5(10):590–6.CrossRef Paiva T, Batista A, Martins P, Martins A. The relationship between headaches and sleep disturbances. Headache. 1995;5(10):590–6.CrossRef
4.
go back to reference Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep. 2008;8(2):167–75.PubMedCrossRef Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep. 2008;8(2):167–75.PubMedCrossRef
5.
go back to reference Nobre ME, Leal AJ, Filho PM. Investigation into sleep disturbance of patients suffering from cluster headache. Cephalalgia. 2005;25(7):488–92.PubMedCrossRef Nobre ME, Leal AJ, Filho PM. Investigation into sleep disturbance of patients suffering from cluster headache. Cephalalgia. 2005;25(7):488–92.PubMedCrossRef
6.
go back to reference Mitsikostas DD, Vikelis M, Viskos A. Refractory chronic headache associated with obstructive sleep apnoea syndrome. Cephalalgia. 2008;28(2):139–43.PubMed Mitsikostas DD, Vikelis M, Viskos A. Refractory chronic headache associated with obstructive sleep apnoea syndrome. Cephalalgia. 2008;28(2):139–43.PubMed
7.
go back to reference Vgontzas A, Cui L, Merikangas KR. Are sleep difficulties associated with migraine attributable to anxiety and depression? Headache. 2008;48(10):1451–9.PubMedCrossRef Vgontzas A, Cui L, Merikangas KR. Are sleep difficulties associated with migraine attributable to anxiety and depression? Headache. 2008;48(10):1451–9.PubMedCrossRef
8.
go back to reference Ohayon MM. Prevalence and risk factors of morning headaches in the general population. Arch Intern Med. 2004;164(1):97–102.PubMedCrossRef Ohayon MM. Prevalence and risk factors of morning headaches in the general population. Arch Intern Med. 2004;164(1):97–102.PubMedCrossRef
9.
go back to reference Barbanti P, Fabbrini G, Aurilia C, et al. A case-control study on excessive daytime sleepiness in episodic migraine. Cephalalgia. 2007;27(10):1115–9.PubMedCrossRef Barbanti P, Fabbrini G, Aurilia C, et al. A case-control study on excessive daytime sleepiness in episodic migraine. Cephalalgia. 2007;27(10):1115–9.PubMedCrossRef
10.
go back to reference Silberstein SD, Lipton RB, Dalessio DJ. Overview, diagnosis, and classification of headache. In: Silberstein SD, Lipton RB, Dodick DW, (Eds). Wolff’s headache and other head pain. 8th edition. Oxford University Press; 2007. Silberstein SD, Lipton RB, Dalessio DJ. Overview, diagnosis, and classification of headache. In: Silberstein SD, Lipton RB, Dodick DW, (Eds). Wolff’s headache and other head pain. 8th edition. Oxford University Press; 2007.
11.••
go back to reference Rains JC, Poceta JS. Sleep-related headaches. Neurol Clin. 2012;30(4):1285–98. A comprehensive review describing the relationship between sleep and headache and its implication in the management of sleep-related headaches. PubMedCrossRef Rains JC, Poceta JS. Sleep-related headaches. Neurol Clin. 2012;30(4):1285–98. A comprehensive review describing the relationship between sleep and headache and its implication in the management of sleep-related headaches. PubMedCrossRef
12.
go back to reference Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia. 2004;24 Suppl 1:1–151. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, second edition. Cephalalgia. 2004;24 Suppl 1:1–151.
13.
go back to reference Alberti A, Mazzotta G, Gallinella E, et al. Headache characteristics in obstructive sleep apnea and insomnia. Acta Neurol Scand. 2005;111:309–16.PubMedCrossRef Alberti A, Mazzotta G, Gallinella E, et al. Headache characteristics in obstructive sleep apnea and insomnia. Acta Neurol Scand. 2005;111:309–16.PubMedCrossRef
14.
go back to reference Dexter JD, Weitzman ED. The relationship of nocturnal headaches to sleep headaches to sleep stage patterns. Neurology. 1970;20:413–519.CrossRef Dexter JD, Weitzman ED. The relationship of nocturnal headaches to sleep headaches to sleep stage patterns. Neurology. 1970;20:413–519.CrossRef
16.
go back to reference Goder R, Fritzer G, Kapsokalvyas A, et al. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia. 2001;21:31–7.PubMedCrossRef Goder R, Fritzer G, Kapsokalvyas A, et al. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia. 2001;21:31–7.PubMedCrossRef
17.
go back to reference Ødegård SS, Engstrøm M, Sand T, Stovner LJ, Zwart JA, Hagen K. Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health Study. J Headache Pain. 2010;11(3):197–206.PubMedCrossRef Ødegård SS, Engstrøm M, Sand T, Stovner LJ, Zwart JA, Hagen K. Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health Study. J Headache Pain. 2010;11(3):197–206.PubMedCrossRef
19.
go back to reference Evers S, Goadsby PJ. Hypnic headache: clinical features, pathophysiology, and treatment. Neurology. 2003;60(6):905–9.PubMedCrossRef Evers S, Goadsby PJ. Hypnic headache: clinical features, pathophysiology, and treatment. Neurology. 2003;60(6):905–9.PubMedCrossRef
20.
go back to reference Pinessi L, Rainero I, Cicolin A, et al. Hypnic headache syndrome: association with REM sleep. Cephalalgia. 2003;23:150–4.PubMedCrossRef Pinessi L, Rainero I, Cicolin A, et al. Hypnic headache syndrome: association with REM sleep. Cephalalgia. 2003;23:150–4.PubMedCrossRef
21.
go back to reference Dodick DW, Mosek AC, Campbell JK. The hypnic (‘alarm clock’) headache syndrome. Cephalalgia. 1998;18:152–6.PubMedCrossRef Dodick DW, Mosek AC, Campbell JK. The hypnic (‘alarm clock’) headache syndrome. Cephalalgia. 1998;18:152–6.PubMedCrossRef
22.
go back to reference Holle D, Wessendorf TE, Zaremba S, et al. Serial polysomnography in hypnic headache. Cephalalgia. 2011;31(3):286–90.PubMedCrossRef Holle D, Wessendorf TE, Zaremba S, et al. Serial polysomnography in hypnic headache. Cephalalgia. 2011;31(3):286–90.PubMedCrossRef
23.
go back to reference Kayed K, Godtlibsen OB, Sjaastad O. Chronic paroxysmal hemicranias IV: “REM sleep locked” nocturnal headache attacks. Sleep. 1978;1(1):91–5.PubMed Kayed K, Godtlibsen OB, Sjaastad O. Chronic paroxysmal hemicranias IV: “REM sleep locked” nocturnal headache attacks. Sleep. 1978;1(1):91–5.PubMed
24.
go back to reference Kayed K, Sjaastad O. Nocturnal and early morning headaches. Ann Clin Res. 1985;17:243–6.PubMed Kayed K, Sjaastad O. Nocturnal and early morning headaches. Ann Clin Res. 1985;17:243–6.PubMed
25.
go back to reference Karli N, Zarifoglu M, Calisir N, Akgoz S. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia. 2005;25(6):444–51. Karli N, Zarifoglu M, Calisir N, Akgoz S. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia. 2005;25(6):444–51.
26.
go back to reference Sachs C, Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep. 1991;14(3):263–6.PubMed Sachs C, Svanborg E. The exploding head syndrome: polysomnographic recordings and therapeutic suggestions. Sleep. 1991;14(3):263–6.PubMed
27.••
go back to reference Tepper SJ, Stewart WJ. Medication-overuse headache. Continuum. 2012:18(4):807–22. This is a nice review article describing the clinical features of medication overuse headache, pathophysiology, prevention, and treatment. PubMed Tepper SJ, Stewart WJ. Medication-overuse headache. Continuum. 2012:18(4):807–22. This is a nice review article describing the clinical features of medication overuse headache, pathophysiology, prevention, and treatment. PubMed
28.
go back to reference Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–83.PubMedCrossRef Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–83.PubMedCrossRef
29.
go back to reference Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry. 1938;39:737.CrossRef Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry. 1938;39:737.CrossRef
30.••
go back to reference Rizzoli PB. Acute and preventive treatment of migraine. Continuum. 2012:18(4):764–82. Nice review article on prevention and treatment of migraine. PubMed Rizzoli PB. Acute and preventive treatment of migraine. Continuum. 2012:18(4):764–82. Nice review article on prevention and treatment of migraine. PubMed
31.••
go back to reference Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363(1):63–70. Nice review article describing the therapeutic value of Triptans in the treatment of acute migraine attacks. PubMedCrossRef Loder E. Triptan therapy in migraine. N Engl J Med. 2010;363(1):63–70. Nice review article describing the therapeutic value of Triptans in the treatment of acute migraine attacks. PubMedCrossRef
32.
go back to reference Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002;22(8):633–58.PubMedCrossRef Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002;22(8):633–58.PubMedCrossRef
33.
go back to reference Baron EP, Tepper SJ. Revisiting the role of ergots in the treatment of migraine and headache. Headache. 2010;50(8):1353–61.PubMedCrossRef Baron EP, Tepper SJ. Revisiting the role of ergots in the treatment of migraine and headache. Headache. 2010;50(8):1353–61.PubMedCrossRef
34.
go back to reference Saper JR, Silberstein S. Pharmacology of Dihydroergotamine and evidence for efficacy and safety in migraine. Headache. 2006;46(4):S171–81.PubMedCrossRef Saper JR, Silberstein S. Pharmacology of Dihydroergotamine and evidence for efficacy and safety in migraine. Headache. 2006;46(4):S171–81.PubMedCrossRef
35.
go back to reference Klapper JA, Stanton J. Clinical experience with patient administered subcutaneous Dihydroergotamine mesylate in refractory headaches. Headache. 1992;32(1):21–3.PubMedCrossRef Klapper JA, Stanton J. Clinical experience with patient administered subcutaneous Dihydroergotamine mesylate in refractory headaches. Headache. 1992;32(1):21–3.PubMedCrossRef
37.
38.
39.
go back to reference Dodick DW, Smith TR, Becker WJ, et al. Botulinum neurotoxin type A for treatment of chronic migraine: PREEMPT 2 trial double-blind phase. Presented at: the International Headache Congress; Philadelphia, Pennsylvania; September 9–13, 2009. Dodick DW, Smith TR, Becker WJ, et al. Botulinum neurotoxin type A for treatment of chronic migraine: PREEMPT 2 trial double-blind phase. Presented at: the International Headache Congress; Philadelphia, Pennsylvania; September 9–13, 2009.
40.••
go back to reference Mauskop A. Nonmedication, alternatives, and complimentary treatments for migraine. Continuum. 2012:18(4):796–806. The efficacy of some of the nonpharmacologic therapies including biofeedback, relaxation technique, herbal medications, and vitamins in the treatment of migraine. PubMed Mauskop A. Nonmedication, alternatives, and complimentary treatments for migraine. Continuum. 2012:18(4):796–806. The efficacy of some of the nonpharmacologic therapies including biofeedback, relaxation technique, herbal medications, and vitamins in the treatment of migraine. PubMed
41.
go back to reference Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with Zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet. 2008;372(9656):2115–23.PubMedCrossRef Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with Zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet. 2008;372(9656):2115–23.PubMedCrossRef
42.•
go back to reference Färkkilä M, Diener HC, Géraud G, Láinez M, Schoenen J, Harner N, et al. COL MIG-202 study group. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomized, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol. 2012;11(5):405–13. Oral lasmiditan, a highly selective 5 HT 1F receptor agonist without vasoconstrictor activity is safe and effective in the acute treatment of migraine. PubMedCrossRef Färkkilä M, Diener HC, Géraud G, Láinez M, Schoenen J, Harner N, et al. COL MIG-202 study group. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomized, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol. 2012;11(5):405–13. Oral lasmiditan, a highly selective 5 HT 1F receptor agonist without vasoconstrictor activity is safe and effective in the acute treatment of migraine. PubMedCrossRef
43.
go back to reference Bartsch T, Paemeleire K, Goadsby PJ. Neurostimulation approaches to primary headache disorders. Curr Opin Neurol. 2009;22(3):262–8.PubMedCrossRef Bartsch T, Paemeleire K, Goadsby PJ. Neurostimulation approaches to primary headache disorders. Curr Opin Neurol. 2009;22(3):262–8.PubMedCrossRef
44.
go back to reference Jürgens TP, Leone M. Pearls and pitfalls: neurostimulation in headache. Cephalalgia. 2013;33(8):512–25.PubMedCrossRef Jürgens TP, Leone M. Pearls and pitfalls: neurostimulation in headache. Cephalalgia. 2013;33(8):512–25.PubMedCrossRef
45.
go back to reference Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. ONSTIM Investigators. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85.PubMedCrossRef Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. ONSTIM Investigators. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85.PubMedCrossRef
46.
47.
go back to reference Ashkenazi A, Matro R, Shaw JW, et al. Greater occipital nerve block using local anesthetics alone or with triamcinolone for transformed migraine: a randomized comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415–7.PubMedCrossRef Ashkenazi A, Matro R, Shaw JW, et al. Greater occipital nerve block using local anesthetics alone or with triamcinolone for transformed migraine: a randomized comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415–7.PubMedCrossRef
48.•
go back to reference Babineau S, Geen M. Headaches in children. Continuum. 2012:18(4):753–68. Detailed discussion of management of headache in children. Babineau S, Geen M. Headaches in children. Continuum. 2012:18(4):753–68. Detailed discussion of management of headache in children.
49.
go back to reference Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006;295(15):1824–30.PubMedCrossRef Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006;295(15):1824–30.PubMedCrossRef
50.••
go back to reference Brandes LS, Green M. Migraine in women. Continuum. 2012:18(4):835–52. Nice review article on the management of headache in women including the role of hormonal manipulation. PubMed Brandes LS, Green M. Migraine in women. Continuum. 2012:18(4):835–52. Nice review article on the management of headache in women including the role of hormonal manipulation. PubMed
51.
go back to reference Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5(1):83–91.PubMedCrossRef Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5(1):83–91.PubMedCrossRef
52.
go back to reference Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012(11);344:e2407. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012(11);344:e2407.
53.
go back to reference Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451–7.PubMedCrossRef Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451–7.PubMedCrossRef
54.
go back to reference Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal Zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006;63(11):1537–42.PubMedCrossRef Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal Zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006;63(11):1537–42.PubMedCrossRef
55.
go back to reference van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal Sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630–3.PubMedCrossRef van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal Sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630–3.PubMedCrossRef
56.
go back to reference Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411–7.PubMedCrossRef Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411–7.PubMedCrossRef
57.•
go back to reference Goadsby PJ. Trigeminal autonomic Cephalalgias. Continuum. 2012;18(4):883–95. A nice review article on the management of cluster headache, paroxysmal hemicranias, and other trigeminal autonomic Cephalalgia. PubMed Goadsby PJ. Trigeminal autonomic Cephalalgias. Continuum. 2012;18(4):883–95. A nice review article on the management of cluster headache, paroxysmal hemicranias, and other trigeminal autonomic Cephalalgia. PubMed
58.
go back to reference Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology. 2007;69(7):668–75.PubMedCrossRef Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology. 2007;69(7):668–75.PubMedCrossRef
59.
go back to reference Leone M, Proietti Cecchini A, Franzini A, Broggi G, Cortelli P, Montagna P, et al. Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache. Cephalalgia. 2008;28(7):787–97.PubMedCrossRef Leone M, Proietti Cecchini A, Franzini A, Broggi G, Cortelli P, Montagna P, et al. Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache. Cephalalgia. 2008;28(7):787–97.PubMedCrossRef
60.
go back to reference Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369(9567):1099–106.PubMedCrossRef Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369(9567):1099–106.PubMedCrossRef
61.•
go back to reference Donnet A, Lantéri-Minet M. A consecutive series of 22 cases of hypnic headaches in France. Cephalalgia. 2009;29:928–34. This study is one of the three case series reported since the individualization of HH by ICHD-II, including a field testing of ICHD-II criteria. PubMedCrossRef Donnet A, Lantéri-Minet M. A consecutive series of 22 cases of hypnic headaches in France. Cephalalgia. 2009;29:928–34. This study is one of the three case series reported since the individualization of HH by ICHD-II, including a field testing of ICHD-II criteria. PubMedCrossRef
62.
63.
go back to reference Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T, et al. Standards of practice committee; American Academy of Sleep Medicine. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8):1031–5.PubMed Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T, et al. Standards of practice committee; American Academy of Sleep Medicine. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8):1031–5.PubMed
64.
go back to reference Nath Zallek S, Chervin RD. Improvement in cluster headache after treatment for obstructive sleep apnea. Sleep Med. 2001;1(2):135–8.CrossRef Nath Zallek S, Chervin RD. Improvement in cluster headache after treatment for obstructive sleep apnea. Sleep Med. 2001;1(2):135–8.CrossRef
65.
go back to reference Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J. 1999;13(5):1086–90.PubMedCrossRef Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J. 1999;13(5):1086–90.PubMedCrossRef
66.•
go back to reference Kaniecki RG. Tension-type headache. Continuum. 2012;18(4):823–34. Very nice review article on the management of tension type headache. PubMed Kaniecki RG. Tension-type headache. Continuum. 2012;18(4):823–34. Very nice review article on the management of tension type headache. PubMed
67.
go back to reference Fumal A, Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol. 2008;7(1):70–83.PubMedCrossRef Fumal A, Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol. 2008;7(1):70–83.PubMedCrossRef
68.
go back to reference Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279(5):381–3.PubMedCrossRef Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998;279(5):381–3.PubMedCrossRef
Metadata
Title
Sleep-Related Headache and its Management
Publication date
01-12-2013
Published in
Current Treatment Options in Neurology / Issue 6/2013
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-013-0258-1

Other articles of this Issue 6/2013

Current Treatment Options in Neurology 6/2013 Go to the issue

SLEEP DISORDERS (S CHOKROVERTY, SECTION EDITOR)

Complex Sleep Apnea

SLEEP DISORDERS (S CHOKROVERTY, SECTION EDITOR)

Comorbid Insomnia and Sleep Disordered Breathing

DEMENTIA (E MCDADE, SECTION EDITOR)

Treatment of Dementia With Lewy Bodies